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Myocardial stretch, as result of acute hemodynamic overload, is one of the most
frequent challenges to the heart and the ability of the heart to intrinsically adapt
to it is essential to prevent circulatory congestion. In this review, we highlight the
historical background, the currently known mechanisms, as well as the gaps in
the understanding of this physiological response. The systolic adaptation to stretch
is well-known for over 100 years, being dependent on an immediate increase in
contractility—known as the Frank-Starling mechanism—and a further progressive
increase—the slow force response. On the other hand, its diastolic counterpart remains
largely unstudied. Mechanosensors are structures capable of perceiving mechanical
signals and activating pathways that allow their transduction into biochemical responses.
Although the connection between these structures and stretch activated pathways
remains elusive, we emphasize those most likely responsible for the initiation of the acute
response. Calcium-dependent pathways, including angiotensin- and endothelin-related
pathways; and cGMP-dependent pathways, comprising the effects of nitric oxide and
cardiac natriuretic hormones, embody downstream signaling. The ischemic setting, a
paradigmatic situation of acute hemodynamic overload, is also touched upon. Despite
the relevant knowledge accumulated, there is much that we still do not know. The quest
for further understanding the myocardial response to acute stretch may provide new
insights, not only in its physiological importance, but also in the prevention and treatment
of cardiovascular diseases.
Keywords: cardiac function, frank starling mechanism, myocardial stretch, neurohumoral adaptation, slow force
response
INTRODUCTION
The heart has a central role in the maintenance of cardiovascular homeostasis, which requires the
ability to continuously adapt its function to different hemodynamic conditions.
One of the most frequent challenges to myocardium is acute stretch, as result of acute
hemodynamic overload. Acute myocardial stretch can be observed in various physiological and
pathophysiological conditions (e.g., exercise, myocardial ischemia, hypertensive crises, valvular
diseases, and heart failure). For example, at the start of aerobic exercise (Figure 1), the pumping
action of skeletal muscle contraction increases the venous return, leading to cardiac chamber
dilation and acute myocardial stretch (Nóbrega et al., 1995). This increase in end-diastolic volume
leads to an increase in end diastolic pressure that, in the absence of adequate response, would lead
to pulmonary and systemic congestion.
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FIGURE 1 | Acute cardiac overload. Schematic example of the normal
intrinsic adaptation of the left ventricle to acute increase in preload. In this
example, the additional modulation by autonomic nervous system is ignored,
in order to highlight the intrinsic myocardial response to acute stretch.
Myocardial stiffness changes in response to acute myocardial stretch have not
yet been adequately evaluated. EDP, End Diastolic Pressure; VR, Venous
Return; CO, Cardiac Output; AT, Active Tension; St, Myocardial Stiffness.
Being such a common challenge, one can expect the heart
to have adequate intrinsic physiologic mechanisms to respond
to this stimulus. The adequate physiological response to the
acute increase in end-diastolic pressure must include: activation
of stretch sensing molecules (the sensing organ), intermediary
mechanisms (afferent, integrator and efferent pathways), and
effector mechanisms that would ultimately allow the heart to
reduce its increased end-diastolic pressure (Figure 1). This could,
in theory, be achieved by two different mechanisms:
- A systolic adaptation: an increase in contractility, leading to an
increased ejection volume and, consequently, a decreased end
diastolic volume.
- A diastolic adaptation: an increase in cardiac compliance,
which would allow accommodating more blood at inferior end
diastolic pressures.
Both adaptations would increase cardiac output, which would
also be appropriate to offset the increase in venous return.
The first described mechanism of cardiac adaptation to an
acute hemodynamic overload has been known for about a
century (Katz, 2002). An increase in either venous return or
aortic resistance leads to an increased end-diastolic volume and
to an immediate increase in contractility and stroke volume.
This response is presently known as Frank-Starling Mechanism
(FSM) due to the contribution of Ernest H. Starling and Otto
Frank to its description (Patterson and Starling, 1914; Frank,
1959) and given its relevance for the cardiovascular homeostasis
it is also known as the “law of the heart.” This response is
mainly attributed to enhanced myofilamental responsiveness
to Ca2+. There is a direct proportionality between sarcomere
length and the sensitivity of the sarcomere to Ca2+, such
that more force is generated at a given concentration of
Ca2+ as sarcomere length is increased (de Tombe, 2003).
Several mechanisms have been proposed for this myofilament
length dependent activation: the degree of thin and thick
myofilaments overlap may determine the potential availability
of cross-bridges (Endoh, 2008); the reduction of the distance
between the thick and thin filaments with the elongation of
the sarcomere may contribute to the approximation of the
myosin heads to actin increasing the probability of strong cross-
bridge formation (Irving et al., 2000) or the increased titin’s
passive tension may potentiate the binding between the actin
and the myosin filaments, contributing to an increase in the
contraction force (Fukuda and Granzier, 2005). More recently,
it was proposed by de Tombe et al. that a length modulated
regulation of thin filament activation state, rather than a more
direct mechanism involving myosin–actin affinity, mediates the
myofilament length dependent activation (de Tombe et al.,
2010).
In 1912, von Anrep described that, after the initial change
in muscle length and contractility induced by clamping the
heart outflow, it is observed a progressive and time-dependent
increase in force development that goes beyond the force
immediately achieved after stretch and is responsible for the
return of end-diastolic volume back to its original value
(Von Anrep, 1912). This second progressive increase in force
development, was demonstrated in vitro by Parmley and Chuck
in 1973, being since then synonymously called slow force
response (SFR; Parmley and Chuck, 1973). Contrarily to the
FSM, the main mechanism responsible for the SFR appears
to be a progressive increase in Ca2+ transient (Alvarez et al.,
1999).
The myocardial response to stretch is dependent on the
phosphorylation status of cardiomyocytes proteins. Several
signaling pathways are known to induce phosphorylation
or dephosphorylation of sarcomeric proteins and ion
channels. Phosphorylation of troponin I (TnI) results in
reduction of myofilament Ca2+ sensitivity and an increase in
crossbridge cycling rate, leading to acceleration of relaxation
and an increased contractility (Layland et al., 2005). Myosin
binding protein C (MyBP-C) phosphorylation increases
actin–myosin crossbridge kinetics, also enhancing relaxation
and contraction (Mamidi et al., 2014). On the other hand,
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titin phosphorylation is associated with a modulation of its
passive tension (and consequently cardiomyocyte passive
tension), either decreasing or increasing it, according to
the site of phosphorylation (Castro-Ferreira et al., 2011).
Phosphorylation of L-Type Ca2+ channel and SR Ca2+ release
channel (ryanodine receptor, RyR2) are associated with an
increased Ca2+ transient improving the contractile function
(Berridge et al., 2003). Phospholamban (PLB) is another protein
frequently targeted for phosphorylation; its phosphorylation
disinhibits the sarco/endoplasmic reticulum Ca2+ ATPase
(SERCA) increasing the uptake of cytoplasmic Ca2+ which
improves both relaxation (by hastening the decrease in free
Ca2+ concentration) and contraction (by increasing the Ca2+
available for release by the sarcoplasmic reticulum; Berridge
et al., 2003).
Both FSM and SFR highlight a highly effective systolic
adaptation to an acute hemodynamic overload. A diastolic
adaptation per se, although theoretically appropriate to the
underlying challenge, remains largely unknown. Until this
moment, no single study directly evaluated the diastolic response
to an acute myocardial stretch. Throughout this review, we will
emphasize the mechanisms that suggest that a simultaneous
diastolic adaptation is highly probable.
In this paper, about 100 years after the initial publication
of E. Starling about the relevance of stretch to heart function,
we intend to review the great progress in understanding of the
myocardial adaptation to acute stretch, as well as highlight the
gaps in the understanding of this mechanism.
Myocardial Mechanosensing
Mechanosensors are structures capable of perceiving mechanical
signals and activating pathways that allow transduction of the
signal into biochemical responses. The external forces exerted
on the myocardium are transmitted through the sarcolemma
(and associated adhesion structures: intercalated disks and
costameres), cardiomyocyte cytoskeleton, and sarcomeric
proteins. Concurrently, the sarcomeres generate forces that
propagate in the opposite direction. Several mechanosensor
molecules in this mechanical chain have been identified, being
the best characterized ones located in Z-line, titin molecule,
sarcolemma, intercalated disks, and costameres.
Recent reviews (Takahashi et al., 2013; Buyandelger et al.,
2014; Lyon et al., 2015) addressed cardiac mechanotransduction
in detail, particularly its relation to remodeling and chronic
adaptation. The precise role of mechanosensors in the acute
response to stretch is still mostly unknown, as few studies have
directly addressed this issue. Therefore, in this topic, we intend
to emphasize the great diversity of mechanosensors in the heart
and highlight cellular components that, given their structure,
mechanism of action and activated signaling pathways, may
potentially contribute to the response to acute stretch (Figure 2).
The Z-line divides two adjacent sarcomeres and is traditionally
regarded as an essential element to the normal structural
arrangement of the sarcomeres. However, its position confers
to the Z disk the distinct ability to sense the muscular tension,
during either the diastolic or the systolic period (Hoshijima,
2006). The Z-line is composed not only of overlapping actin
FIGURE 2 | Myocardial mechanosensing. Acute myocardial stretch induces an increased myocardial tension that can be sensed by several potential
mechanosensors.The connections between mechanosensors and activated signaling pathways are not yet fully understood. CN, calcineurin; ERK, extracellular
signal-regulated kinase; FAK, focal adhesion kinase; PDE, phosphodiesterase; PKC, protein kinase C; SAC, stretch-activated channel.
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filaments of adjacent sarcomeres tightly linked by α-actinin, but
also of numerous proteins bearing diverse signaling functions
(Luther, 2009). Many of these proteins may be relevant for
response to acute stretch, including: Protein Kinase C (PKC) ε
(Robia et al., 2005), PKCδ (Disatnik et al., 1994), calcineurin (Frey
et al., 2000), and phosphodiesterase 5 (Senzaki et al., 2001).
Titin is a giant protein that spans the sarcomere from
the Z-line to the M-line. Its molecular structure makes this
protein work as a bidirectional spring that determines the
myocardial passive tension at different lengths (Castro-Ferreira
et al., 2011). In addition to its structural and elastic function,
titin also functions as a biomechanical sensor sensing myocardial
tension as well as the sarcomeric length. The central role of
titin in mechanosensing and its ability to trigger downstream
signaling cascades is related to its interactions with numerous
structural proteins and signaling proteins at its M-band, Z-line,
N2B, N2A, and PEVK-domains (Linke and Krüger, 2010).
Titin also features a kinase domain near the carboxyl-terminal
(located in the M-line region; Mayans et al., 1998), which
may phosphorylate target proteins at specific sites, according to
myocardial stretching (Puchner and Gaub, 2010). Moreover, titin
presents various phosphorylation sites of its own at PEVK and
N2B domains (Krüger and Linke, 2011), whose phosphorylation
alters passive tension conferred by titin, either decreasing or
increasing it (Ahmed and Lindsey, 2009). This mechanism
confers titin a special role in mechanosensing, allowing it to
simultaneous function as a mechanosensor and a molecular
target. Therefore, it is tempting to hypothesize that upon an
increase in acute passive tension, titin is capable of initiating
a compensatory mechanism that, ultimately, would lead to
decreased titin’s passive tension with consequent normalization
of sarcomeric passive tension. It is important to highlight
that, as the main determinant of myocardial passive tension,
modifications of titin phosphorylation status will also modify the
activity of remaining mechanosensors.
The sarcolemma separates the intracellular and extracellular
environments. This structure is teeming with different receptors
subject to activation by extracellular mediators that set different
intracellular pathways in motion. However, several sarcolemma
proteins can also be activated by cellular stretch, initiating
intracellular pathways without binding of extracellular mediators
(Storch et al., 2012). Stretch activated channels (SACs) are a
paradigmatic example of this type of activation in cytoplasmic
membranes (Reed et al., 2014). In cardiomyocytes, upon stretch,
SACs are permeable to sodium, potassium and calcium, thereby
modulating electrical and mechanical properties of myocardium.
The AT1 receptor, a G protein-coupled receptor, can also
be directly activated by stretch without the involvement of
angiotensin II (Zou et al., 2004). This agonist-independent
activation may have a determinant role in the myocardial
response to acute stretch. The blockade of this receptor has been
associated with a significantly blunted SFR (Heidkamp et al.,
2003).
The interaction of cardiomyocytes with neighboring cells
(at intercalated discs) and with the extracellular matrix (at
costameres) is key to the maintenance of the structural
integrity of the myocardium, as well as the transmission
of forces between cells (Kresh and Chopra, 2011). Beyond
this function, some components of intercalated discs and
costameres are known to be involved in mechanosensing
(Samarel, 2005). At the level of intercalated discs, the main
structures capable of contributing to mechanosensing are
fascia adherens junctions (constituted by N-cadherin and
associated multi-molecular complex anchoring cytoskeletal
actin) and desmosomes (composed of the cell adhesion proteins
desmoglein and desmocollin and associated proteins internally
linked to the intermediate filament desmin; Sheikh et al.,
2009). Both structures are known to contribute to long-term
cytoskeletal adaptive responses to different pathophysiological
forces (Lyon et al., 2015), but their importance in the
acute response remains unknown. Regarding costameres, one
important component contributing to mechanosensing are
integrins. These heterodimeric transmembrane receptors located
at costameres contribute to the connection between extracellular
matrix and the intracellular cytoskeleton, and therefore, to the
transmission of mechanical signals to the cytoskeleton (Israeli-
Rosenberg et al., 2014). One well-known mediator of integrin
mechanosensing is focal adhesion kinase (FAK; Domingos et al.,
2002b). The signaling resultant of FAK activation is proportional
to the magnitude and duration of mechanical stretch (Katz et al.,
2002). FAK activity is also related to various signaling pathways
potentially relevant to the acute response to stretch, including
ERK1/2 (Domingos et al., 2002a) and PKC ε (Heidkamp et al.,
2003). Another mediator that may be particularly important
for the acute transduction of integrin signaling is integrin-
linked kinase (ILK). ILK appears to mediate cardiomyocyte
force transduction via regulation of the SERCA activity and
phosphorylation of PLB (Traister et al., 2014), which may
contribute both to the systolic and diastolic adaptation to acute
stretch.
Although several potential mechanosensing molecules have
been identified, the connection between these molecules and
stretch activated pathways remains elusive. This lack of
knowledge is even more pronounced when it comes to the acute
activation of these pathways by these molecules. Furthermore,
the interrelation between those sensors is complex, and the
spread synergism and crosstalk between the pathways activated
downstream of those sensors lead to a broad activation of
signaling pathways that acutely modulate heart function, which
is probably crucial to the ability of myocardium to adapt to acute
hemodynamic overload.
Calcium-Dependent Pathways
Calcium (Ca2+) is the central player in the biphasic systolic
adaptation to myocardial stretch. Besides its involvement in the
FSM, an increase in the intracellular concentration of Ca2+
underlies the SFR (Figure 3). Angiotensin-II (ANG-II) and
endothelin (ET) are two peptide hormones (8 and 21 amino
acids long, respectively) that share some interesting features.
Via binding to receptors coupled to protein Gq and subsequent
release of Ca2+ from intracellular stores and activation of PKC,
they increase cardiac inotropism and have a pressor effect on
blood vessels (Figure 3). Though they normally play a role in
the physiological regulation of blood pressure by altering salt and
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FIGURE 3 | Integrated signaling pathways. Diagram representing the molecular interplay between the various players in the acute response to stretch. The same
mediators may exert different effects depending on the subcellular compartment. Question marks indicate yet unknown mechanisms. The proposed model is based
on data obtained from different species and experimental models. Some signaling pathways may differ between species. ANG-II, angiotensin-II; CNH, cardiac
natriuretic hormone; EGFR, epidermal growth factor receptor; ET, endothelin; ERK, extracellular signal-regulated kinase; HBEGF, heparin-binding epidermal growth
factor; MMP, matrix metalloproteinase; NCX, sodium-calcium exchanger; NHE, sodium-proton exchanger; nNOS, neuronal NO synthase; PDE, phosphodiesterase;
pGC-A, particulate guanylate cyclase A; PK, protein kinase; PLB, phospholamban; PLC, phospholypase C; ROS, reactive oxygen species; Ryr2, ryanodine receptor
2; sGC, soluble guanylate cyclase.
water balance and vasomotor tone (especially in renal vessels),
they have been implicated in the pathophysiology of pulmonary
and systemic hypertension and heart failure (Brunner et al., 2006;
Mehta and Griendling, 2007).
More recently, the study of the role of local angiotensin
and endothelin systems in cardiac function and pathophysiology
has been prolific. These have been implicated in the process of
cardiac remodeling that takes place as a result of neurohumoral
activation in congestive heart failure (Brunner et al., 2006;
De Mello and Frohlich, 2011) but they also seem to be
central in the modulation of the acute myocardial response
to stretch, contributing to the genesis of the FSM and the
development of the SFR (Cingolani et al., 2011). In fact,
Sadoshima et al. first demonstrated that cultured neonatal
cardiomyocytes directly released ANG-II from intracellular
vesicles in response to an acute 10 or 30min stretch, generating
a concentration of around 1 nM in the culture medium
(Sadoshima et al., 1993). The positive inotropic response to
acute stretch is similar to that elicited by addition of exogenous
ANG-II in amounts of the same order of magnitude and
can be blocked by inhibition of AT1 but not AT2 receptors
(Caldiz et al., 2007). However, this effect seems to depend
on downstream release of ET, as inhibition of ET receptors,
as well as the ET converting enzyme, ablated both the SFR
and the increase in contractility that accompanies ANG-II
administration but AT1 receptor blocking did not prevent the
positive inotropic effect of exogenous ET (Pé´rez et al., 2003).
Accordingly, Anderson et al. reported that ET synthesis in
myocytes increases followingmyocardial stretch (Anderson et al.,
2004).
Taking these results into account, along with their
own, Cingolani’s group has since described a complex
autocrine/paracrine pathway involving changes in membrane
ion currents mediated by ANG-II and ET that sheds some
light on the role played by these molecules in the response to
myocardial stretch (Cingolani et al., 2011). They propose that
the initial step in generating the SFR is an ANG-II dependent
release of endogenous ET by poorly described mechanisms that
may involve activation of the mineralocorticoid receptor by
aldosterone or another non-identified ligand.
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Although all three endothelin isoforms have equal positive
inotropic potency when exogenously administered, ET-3 is
the most likely to be responsible for SFR in a physiological
setting (Ennis et al., 2005). The ET receptor then transactivates
the epidermal growth factor receptor (EGFR) through various
pathways. The best described one involves activation of matrix
metalloproteinases and subsequent release of heparin-binding
epidermal growth factor (HBEGF), which binds to and activates
EGFR. This supposedly triggers an intracellular signaling
pathway leading to increased production and release of reactive
oxygen species (ROS) by mitochondriae through opening of
mitochondrial KATP channels (Anderson et al., 2004; Villa-
Abrille et al., 2010). Redox-sensitive kinases ERK1/2 and p90rsk
therefore, increase their activity in response to stretch and
phosphorylate the regulatory domain of the sodium-proton
exchanger 1 (NHE1), increasing its activity and cytoplasmic
[Na+]. This transporter has long been implicated in the
development of the SFR and this is thought to occur through
modulation of ion electrochemical gradients that the increased
[Na+] provokes. In this setting, the sodium-calcium exchanger
(NCX), which usually extrudes calcium, reverses direction of
transport, increasing the amplitude of Ca2+ transients and,
consequently, contractile force (Figure 3).
On the other hand, the increased Ca2+ transient, through
favored actin-myosin interaction, could result in alarming levels
of muscle stiffness. Thus, it is not surprising that other stretch
activated mechanisms promote muscle relaxation by improving
Ca2+ extrusion from cytosol after myocardial contraction.
In fact, there is a well-described acute increase in SERCA
expression following hemodynamic overload (Kögler et al.,
2006). Besides, Ca2+ load following stretch binds to the several
Ca2+ binding proteins in the heart, with S100A1 being the most
abundant member of the calcium-binding S100 protein family
in myocardial tissue (Duarte-Costa et al., 2014). S100A1-Ca2+
complex frees the actin from titin, reducing the passive tension
imposed by titin-actin interaction (Yamasaki et al., 2001). The
relative importance of thesemechanisms in the passive properties
of the heart following stretch has not been studied in detail.
The complex loop involving ANG-II and ET still has gaps to be
filled and seemingly contradictory results exist in the literature.
Our own results confirm the major role of AT1 receptors and the
NHE-1 and NCX transporters in the development of SFR and
the positive inotropic effect of the external addition of ANG-
II on myocardium in normal conditions, which subsequently
blunts SFR, presumably by saturating the contractile reserve of
the pathway in the absence of stretch. In addition, it points to a
possible role of PKC inmaintaining the SFR during the late phase
of acute stretch (Neves et al., 2013).
Interestingly, our group has also described the role of
these peptides on the acute modulation of diastolic function
through direct effects on both relaxation velocity and myocardial
stiffness. Activation of ETA and AT1 receptors results in positive
lusitropism and decreased stiffness, while ETB and AT2 receptors
promote negative lusitropism. As in its systolic counterpart, AT1
receptor activation seems upstream to endothelin release in the
pathway that leads to faster myocardial relaxation, as this effect
is dependent on ETA receptor activity and an intact endocardial
endothelium (Bras-Silva and Leite-Moreira, 2006; Castro-Chaves
et al., 2006). Concurrently, decreasing stiffness depends on the
activity of both NHE1 and PKC and on the integrity of the
endocardial endothelium (Leite-Moreira et al., 2003, 2006; Bras-
Silva and Leite-Moreira, 2006).
Pathways Involving Nitric Oxide and
Cardiac Natriuretic Hormones
Cardiac stretch stimulates both endothelial cells and
cardiomyocytes to produce nitric oxide (NO; Casadei and
Sears, 2003). In endothelial cells, large amounts of NO are
produced by the endothelial nitric oxide synthase (NOS),
after which it rapidly diffuses to neighboring cardiomyocytes
(Figure 3). In the cardiomyocyte, NO is produced in relatively
low levels by both endothelial NOS and neuronal NOS (nNOS;
Petroff et al., 2001; Khan et al., 2003).
NO actions can be divided in those that are mediated by
an elevation of cGMP (cGMP-dependent effects) and those
that do not depend on cGMP elevation (cGMP-independent
effects). As NO produced by endothelial cells diffuses through
the cardiomyocyte, soluble guanylate cyclase present in the
cytoplasm is activated, leading to an increase in cGMP
concentration in the cytosolic compartment. The effect of cGMP
is mediated through protein kinase G (PKG), which is able to
phosphorylate TnI, rendering a reduction of myofilamentary
sensitivity to calcium, therefore increasing the rate of Ca2+
dissociation (Layland et al., 2005). NO produced by nNOS,
which is located in the sarcoplasmic reticulum membrane,
simultaneously modulates the diastolic properties of the heart
through PKA-dependent phosphorylation of PLB in a cGMP-
independent pathway (Zhang et al., 2008). The phosphorylation
of PLB disinhibits SERCA, which rapidly reuptakes free
cytoplasmic Ca2+. Taken together, NO mediated pathways, both
cGMP-dependent and cGMP-independent pathways, hasten
myocardial relaxation (positive lusitropism), prolonging the
diastolic time interval while reducing the passive tension of
cardiomyocytes. These changes in myocardial properties are
crucial for the heart to accommodate increasing preloads,
without substantial changes in the intracardiac filling pressures
(Figure 3).
Besides altering the diastolic properties of the heart, NO also
modulates its contractility. NO-derived cGMP coexists in the
cytoplasm with several members of the phosphodiesterase (PDE)
family. Proteins of this family are metallophosphohydrolases
that cleave cGMP and/or cAMP to 5′-GMP and 5′-AMP,
inhibiting the activation of PKG and Protein Kinase A (PKA),
respectively (Zaccolo and Movsesian, 2007). Therefore, although
stretch induces an increase in the production of NO, the
cytoplasmic concentration of NO-derived cGMP is kept relatively
low due to continuous hydrolysis mediated by PDE5, located
preferentially in Z-bands, in a cGMP-activated negative feedback
mechanism. An important crosstalk between cGMP and cAMP
pathways occurs, as low concentrations of cGMP inhibit
PDE3, thus preventing the hydrolysis of cAMP (Francis et al.,
2010). Accumulated cytoplasmic cAMP activates PKA, which
is then responsible for the phosphorylation of several proteins
involved in cardiac contraction (Figure 3). These include the
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sarcolemmal voltage-gated L-Type Ca2+ channels, RyR2, PLB,
the phosphatase 1 inhibitor, TnI and MyBP-C, all aiming to
increase myocardial contractility (Fischmeister et al., 2006).
Interestingly, a prolonged activation of RyR2 could ultimately
lead to SR Ca2+ depletion, and consequently to a paradoxal
negative inotropism; however, activation of SERCA, as previously
stated, is able to replenish the SR Ca2+ pool and maintain this
cycle. RyR2 can also be opened via cyclic adenosine diphosphate
ribose, which is produced by a PKG mediated phosphorylation
of adenosine diphosphate ribosylcyclase (Willmott et al., 1996).
NO can also exert an important effect on the systolic properties
of the myocardium per se in a cGMP-independent pathway. NO
produced by nNOS directly S-nitrosylates reactive thiol residues
within RyR2, which also contributes to an increased Ca2+ release
(Wang et al., 2010). Taken together, NOmediated pathways, both
cGMP-dependent and cGMP-independent pathways, enhance
myocardial contractility (positive inotropism) in response to
stretch, allowing the heart to pump more vigorously the
increasing blood volume arriving after each heartbeat (Figure 3).
Accordingly, we recently demonstrated in rabbit papillary
muscles that acute myocardial stretch in the presence of a PKG
inhibitor leads to a significant attenuation of the SFR (Castro-
Ferreira et al., 2014).
Cardiac stretch also stimulates cardiomyocytes to release
cardiac natriuretic hormones (CNH), namely atrial natriuretic
peptide and brain natriuretic peptide. Both exert their cardiac
effect by activating cell surface-associated particulate guanylate
cyclase A, which in turn increases the concentration of
cGMP in the subsarcolemmal compartment (Francis, 2010;
Figure 3). However, in opposition to NO-derived cGMP, whose
concentration is kept low through a PDE5 mediated negative
feedback mechanism, CNH-derived cGMP triggers a feed-
forward mechanism that increases cGMP concentration even
more (Castro et al., 2010). While this important difference is
not reflected in the relaxation properties of the myocardium, as
similarly to NO, CNH exert a positive lusitropic effect through
phosphorylation of PLB and TnI, high levels of cGMP stimulate
PDE2, reducing cAMP levels, which explains the absence of a
positive inotropic effect following CNH release (Potter et al.,
2006).
Both NO and CNH can exert their effects through cGMP;
however, their physiological role may be quite different. The
production/degradation of NO is finely tuned and occurs at
a very high pace, meaning that NO must probably be related
to adaptations to acute stretch on a beat-to-beat basis (e.g.,
in inspiration, changing from orthostatic to lying position).
Contrastingly, and taking into account their diuretic effects in
the kidney and longer half-life than NO, CNH could be more
important in hypervolemic, hypertensive states, where stretch is
prolonged in time, which explains the importance in relaxing
the myocardium without increasing contractility, which would
be deleterious.
Effects of Ischemia on the Myocardial
Response to Acute Stretch
Myocardial ischemia is a paradigmatic situation of acute
hemodynamic overload in which abnormal myocardial loading
activates a variety of cellular responses. During an ischemic event,
several neurohumoral agents are released, which contribute
to the overall physiologic process of cardiac adaptation
to hemodynamic overload. Though significant advances in
knowledge have been made in the last three decades regarding
the processes involved in the pathophysiological consequences
of ischemia per se, the cardiac response to stretch under those
conditions is just taking its first steps.
As previously stated, the myocardial response to stretch is a
two-step adaptive response. The contractile response following
acute stretch under ischemic conditions has been less studied.
In a recent study carried out by our group, it was clearly
demonstrated that this response is profoundly affected, as shown
not only by a blunted FSM but also by the abolishment of
the SFR (Neves et al., 2013), thus supporting some previous
indirect observations (Goto et al., 1988; Owen et al., 1993). In
the human heart, after an occlusion of a coronary artery, pH
falls within 15 s (Poole-Wilson, 1989), possibly contributing to
the loss of contractility (Steenbergen et al., 1977; Patangay et al.,
2009; Decker et al., 2012) due to a reduced sensitivity of the
myofilaments to calcium (Kihara et al., 1989; Salas et al., 2006),
consequently leading to a diminished Ca2+ availability to bind
to troponin C. Metabolic abnormalities should not be excluded,
as they lead to insufficient energy supply to support cardiac
work due to MgADP accumulation, which decreases the sliding
velocity in the vicinity ATPase, slowing down the contraction
cycle (Sata et al., 1996) and impairing the FSM (Robinson
et al., 2002). These mechanisms are probably responsible for
the observed ablation of the SFR in these conditions. A
possible explanation for this was given recently by our group,
demonstrating that this effect was AT1R-dependent and partially
AT2R-dependent: while in the absence of blockade of angiotensin
II receptors the myocardium presents a progressive decrease
in contractility during ischemia, the blockade of AT1R is able
to prevent this deterioration after stretch (Neves et al., 2013).
This effect may also be mediated by AT2R activation through
bradykinin, PKC, and cGMP (Jugdutt and Balghith, 2001).
Little is known about the role of the PKC under ischemic
conditions. As previously stated, PKC activity is more significant
during the late phase of the SFR, preventing the development of
a slow force decline. Also, under ischemic conditions, PKC was
not capable of modifying contractile performance (Neves et al.,
2013). This is consistent with its inability to alter the systolic
adaptation during early phase of the response to stretch and does
not exclude that its downstream mediators may be compromised
in such conditions. However, PKC has several isoforms, some
of them present within the same cell and activated by the same
stimuli but showing different and, at times, opposite effects. For
example, in ischemic heart disease, PKCδ induced decreased
ATP generation (Inagaki et al., 2003), and therefore, insufficient
energy supply may play a role. As such, it would be interesting to
study how each one modulates the contractile response to stretch
under ischemic conditions.
Usually, in the setting of myocardial infarction, the PKG
signaling pathway through NO and CNH is modulated
pharmacologically by nitrates as NO donors. Also,
administration of PDE5 inhibitors may be promising therapeutic
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targets (Kukreja, 2013). However, only recently the specific
role of the PKG signaling pathway in ischemic conditions
was shown. Intriguingly, activation of PKG pathway did not
alter the SFR in ischemic conditions, while PDE5 inhibition
significantly mitigated the contractile decline after stretch in
ischemia (Castro-Ferreira et al., 2014). This can be explained
by NO/cGMP-independent cardioprotective effects (Elrod et al.,
2007). However, the mechanisms responsible for the protective
action of the sildenafil remain to be fully elucidated.
Diastolic Response to Acute Myocardial
Stretch
Contrarily to the systolic adaptation (composed by the well-
characterized FSM and SFR), the existence of a diastolic response
to acute stretch remains unknown, as it has not been directly
evaluated by any study. However, indirect evidence suggests
that a diastolic response to acute myocardial is highly probable.
First, the main determinant of myocardial stiffness, titin, can be
acutely phosphorylated by several signaling pathways that are
activated upon stretch, including calcium-dependent pathways,
and pathways involving NO and CNH (Ladeiras-Lopes et al.,
2009). Furthermore, the phosphorylation of titin by those
pathways is known to induce important changes in diastolic
cardiomyocyte properties that may be of physiological relevance
(Castro-Ferreira et al., 2011). On the other hand, most of the
sarcomeric proteins and ion channels involved in the SFR, are
also known to have an impact in diastolic function: for example,
the increased phosphorylation of TnI and of MyBPC are known
to improve relaxation (Layland et al., 2005; Mamidi et al.,
2014). Similarly, the increased activity of SERCA aftermyocardial
stretch probably contributes to a decreased concentration of
diastolic cytosolic free Ca2+ and, thus to a decreased stiffness
dependent of myosin-actin interaction during the diastolic
period (Ladeiras-Lopes et al., 2009).
The relative importance of this potential mechanism of
diastolic adaptation in comparison to the systolic adaptation is
obviously also unknown. The most probable is that the diastolic
adaptation interacts with the systolic adaptation to allow a
complete response to hemodynamic challenges. It is tempting to
hypothesize that a decreased diastolic reserve and an inability to
develop a diastolic response to acute stretch contributes to the
pathophysiology of heart failure with preserved ejection fraction.
Those patients are known to have a low exercise capacity, a
poor tolerance to volume overload, and a high risk of acute
pulmonary edema (Aurigemma and Gaasch, 2004; Maeder and
Kaye, 2009), all potentially explained by a failure of the left
ventricle to improve its diastolic function in response to a
hemodynamic overload leading to an excessive end diastolic
pressure and consequently to pulmonary congestion. The need to
design studies to directly evaluate the diastolic response to acute
stretch is in our opinion a priority in this field, as it may unravel
a completely new pathway of research.
CONCLUSION
The myocardial response to acute stretch represents a
fundamental adaptive capacity of the heart. Although this
functional response to hemodynamic overload has been known
for long time, the structures responsible for mechanosensing,
as well as the pathways involved in the response, are still only
partially clarified. The possibility of concomitant diastolic
adaptation, although theoretically appropriate, has never been
directly assessed.
Despite the relevant knowledge accumulated on the cardiac
response to acute hemodynamic overload, there is much that
we still do not know. The quest for further understanding of
the mechanosensing involved in this mechanism, the pathways
responsible for the response and the characterization of the
diastolic adaptation may provide new insights, not only in
its physiological importance, but also in the prevention and
treatment of cardiovascular diseases, such as heart failure with
reduced ejection fraction, heart failure with preserved ejection
fraction, hypertensive crises or ischemic heart disease.
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